Risk-adapted salvage treatment with single or tandem autologous stem-cell transplantation for first relapse/refractory Hodgkin's lymphoma: results of the prospective multicenter H96 trial by the GELA/SFGM study group (Q82653415)
Jump to navigation
Jump to search
scientific article published on 17 November 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Risk-adapted salvage treatment with single or tandem autologous stem-cell transplantation for first relapse/refractory Hodgkin's lymphoma: results of the prospective multicenter H96 trial by the GELA/SFGM study group |
scientific article published on 17 November 2008 |
Statements
Risk-adapted salvage treatment with single or tandem autologous stem-cell transplantation for first relapse/refractory Hodgkin's lymphoma: results of the prospective multicenter H96 trial by the GELA/SFGM study group (English)
Franck Morschhauser
Pauline Brice
Christophe Fermé
Marine Diviné
Gilles Salles
Reda Bouabdallah
Catherine Sebban
Laurent Voillat
Aspasia Stamatoullas
Krimo Bouabdallah
Marc André
Jean-Philippe Jais
Dominique Cazals-Hatem
Christian Gisselbrecht
GELA/SFGM Study Group
17 November 2008